Utidelone has the ability to cross BBB due to its unique physicochemical characteristic and insusceptibility to P-glycoprotein-mediated efflux
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Subscribe To Our Newsletter & Stay Updated
